FLGR-242 2mg — Vial Spec, Reconstitution Math & COA

A 2mg vial of FLGR-242 provides a defined, high-purity lyophilized mass engineered for precise in vitro and preclinical research applications. Designed for academic and private laboratories conducting targeted pathway investigations, this standard unit mass allows researchers to prepare consistent working stock solutions across cellular and animal model assays. PX1 Research delivers analytical-grade research compounds backed by lot-specific laboratory verification to ensure experimental reproducibility.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A 2mg vial of FLGR-242 provides a defined, high-purity lyophilized mass engineered for precise in vitro and preclinical research applications. Designed for academic and private laboratories conducting targeted pathway investigations, this standard unit mass allows researchers to prepare consistent working stock solutions across cellular and animal model assays. PX1 Research delivers analytical-grade research compounds backed by lot-specific laboratory verification to ensure experimental reproducibility.

Reviewed by PX1 Research scientific team

Key takeaways

  • A 2mg vial of FLGR-242 contains a sterile, lyophilized cake composed of pure peptide sequence along with stabilizing excipients tailored for structural preservation during vacuum-drying.
  • Accurate dilution calculations are critical for maintaining uniform concentration across experimental replicates.
  • FLGR-242 is an engineered peptide derivative derived from follistatin-domain structures, synthesized specifically to study the regulation of Transforming Growth Factor-beta (TGF-β) superfamily ligands.
  • Once reconstituted, peptide solutions can suffer structural degradation if subjected to repeated temperature fluctuations.

Overview of the FLGR-242 2mg Research Specification

A 2mg vial of FLGR-242 contains a sterile, lyophilized cake composed of pure peptide sequence along with stabilizing excipients tailored for structural preservation during vacuum-drying. This specific mass quantity is routinely selected by research teams performing small- to mid-scale pilot studies, high-content screening, or receptor-binding assays where precise volumetric concentration control is essential.

Investigators often select 2mg mass configurations to minimize reagent waste during exploratory experimental phases. By preparing working solutions in 2mg increments, bench scientists reduce the number of freeze-thaw cycles that stock containers undergo, thereby maintaining maximal bioactivity over extended experimental windows. Researchers evaluating current catalogue inventory can browse our complete index via all peptides or inspect specific batch specifications directly on the FLGR-242 product page.

Reconstitution Mathematics for 2mg Mass Configurations

Accurate dilution calculations are critical for maintaining uniform concentration across experimental replicates. When working with a 2mg (2,000 µg) lyophilized cake of FLGR-242, the added volume of sterile diluent directly dictates the final stock concentration. Standard laboratory protocols utilize bacteriostatic water, sterile normal saline (0.9% NaCl), or assay-compatible buffers such as phosphate-buffered saline (PBS).

To achieve target concentrations, researchers can apply the following standard volumetric diluent ratios for a 2mg vial:

1.0 mL Diluent Addition: Adding 1.0 mL of reconstituting solvent yields a final stock concentration of 2.0 mg/mL (2.0 µg/µL). This concentrated formulation is ideal for low-volume micropipetting into high-density cell culture plates.

2.0 mL Diluent Addition: Adding 2.0 mL of solvent results in a stock concentration of 1.0 mg/mL (1.0 µg/µL). This 1:1 mass-to-volume ratio simplifies calculations during serial dilution series.

3.0 mL Diluent Addition: Adding 3.0 mL of solvent yields a stock concentration of approximately 0.67 mg/mL (0.67 µg/µL), suitable for assays requiring larger injection or dosing volumes in preclinical animal models.

For quick verification of custom concentration targets or multi-vial master mixes, researchers are encouraged to utilize our interactive reconstitution calculator to eliminate mathematical variance prior to liquid handling.

Mechanistic Overview of FLGR-242 in Preclinical Models

FLGR-242 is an engineered peptide derivative derived from follistatin-domain structures, synthesized specifically to study the regulation of Transforming Growth Factor-beta (TGF-β) superfamily ligands. Preclinical studies suggest that FLGR-242 functions primarily by binding to and neutralizing negative regulators of muscle mass, most notably myostatin (GDF-8) and activin A.

In vitro binding assays indicate that FLGR-242 exhibits a high binding affinity for myostatin, blocking its ability to interact with the Activin type IIB receptor (ActRIIB). By sequestering circulating or localized myostatin, the compound downstream modulates Smad2/3 phosphorylation signaling pathways. Researchers utilizing PX1 Research compounds in cell culture models observe alterations in myoblast proliferation and differentiation markers, providing valuable insights into hypertrophic pathways and cellular catabolism.

Aliquot Planning and Laboratory Workflow Optimization

Once reconstituted, peptide solutions can suffer structural degradation if subjected to repeated temperature fluctuations. To preserve the molecular integrity of reconstituted FLGR-242 2mg, laboratories should implement a strict aliquoting protocol immediately following full dissolution.

After reconstituting the 2mg cake with the chosen diluent, gentle swirling (avoiding high-shear vortexing) ensures complete solvation. The stock solution should then be sub-aliquoted into single-use, low-binding polypropylene micro-centrifuge tubes. Standard aliquot sizes typically range from 50 µL to 200 µL depending on the daily consumption requirements of the laboratory's experimental design. Working aliquots should be maintained at 4°C for immediate short-term use (1–7 days) or frozen at -20°C to -80°C for extended storage.

Quality Control & Lot-Matched COA Integrity

Experimental validity depends entirely on compound purity and batch-to-batch consistency. PX1 Research enforces rigorous quality assurance standards, subjecting every manufactured lot of FLGR-242 to comprehensive analytical testing before release.

Every batch undergoes High-Performance Liquid Chromatography (HPLC) to verify chemical purity—consistently exceeding 98%—alongside Mass Spectrometry (MS) to confirm exact molecular mass. Furthermore, total endotoxin levels are quantified using standardized Limulus Amebocyte Lysate (LAL) testing to ensure compatibility with sensitive cell cultures and in vivo animal models. Researchers can review and download lot-specific documentation directly via our dedicated certificate of analysis portal.

Comparative Analysis: FLGR-242 vs. Related Myostatin Regulators

When designing protocols targeting the myostatin/activin pathway, researchers frequently evaluate FLGR-242 alongside alternative peptide analogs and recombinant proteins. Understanding structural and functional differences allows investigators to select the precise tool for their assay conditions.

Compared to native proteins like follistatin 344 or truncated variants like follistatin 315, FLGR-242 is engineered to isolate core binding motifs while optimizing peptide stability and solubility. While soluble receptor decoys like ACE-031 target the ActRIIB receptor complex directly, FLGR-242 focuses on ligand-specific neutralisation. This mechanistic distinction provides researchers with a refined methodology for dissecting pathway-specific signal transduction without broader systemic receptor blockade.

Storage Parameters and Stability Profiling

To maintain analytical validity, proper handling and storage environment must be maintained from receipt through experiment completion. Lyophilized FLGR-242 is exceptionally stable when stored under cold, dry conditions.

Upon arrival, un-reconstituted 2mg vials should be stored at -20°C in a desiccated environment. Under these conditions, the lyophilized peptide cake maintains stability for up to 24 months. Exposure to light, moisture, and elevated ambient temperatures must be strictly avoided. Reconstituted stock solutions prepared with bacteriostatic water exhibit extended stability at 4°C for up to 28 days due to the presence of 0.9% benzyl alcohol, whereas saline or PBS reconstitutions should be consumed or frozen within 24 to 48 hours to prevent bacterial contamination or peptide aggregation.

Evaluating Mass Options: When 2mg is the Optimal Selection

Selecting the correct mass format depends on experimental design, throughput requirements, and budget optimization. A 2mg vial mass represents an ideal balance between reagent volume and fresh working-solution turnover.

For small exploratory studies, single-cell dose-response curves, or initial validation assays, a 2mg vial provides adequate compound mass while minimizing long-term storage of reconstituted liquid. Conversely, laboratories executing large-scale, continuous animal studies or high-throughput screens may require higher total mass or bulk fulfillment. Academic and commercial institutions planning extensive research programs can explore tiered institutional pricing and volume options through our wholesale lab account portal.

Sourcing Integrity and PX1 Research Supply Assurance

PX1 Research operates as a trusted USA-based supplier of premium research peptides, adhering to strict manufacturing standards in GMP-compliant facilities. Every lot of FLGR-242 is synthesized under ISO 17025 accredited laboratory oversight to guarantee accurate sequencing, optical clarity, and strict endotoxin compliance.

To prevent project delays, PX1 Research maintains immediate inventory ready for dispatch from our dual distribution facilities in California and Arizona. Orders placed Monday through Friday ship same-day, ensuring fast delivery and maintaining cold-chain integrity across domestic transport routes.

Frequently Asked Questions

What is the physical appearance of a 2mg FLGR-242 vial upon delivery?

FLGR-242 2mg is delivered as a dry, white to off-white lyophilized plug or powder in a sealed, sterile glass vial under vacuum. It must be reconstituted prior to laboratory use.

How is the concentration calculated when adding 2mL of bacteriostatic water to a 2mg vial?

Dividing the total mass (2mg / 2,000µg) by the total volume (2mL / 2,000µL) results in a concentration of 1.0 mg/mL, or exactly 1.0 µg per microliter.

Can FLGR-242 be reconstituted in plain sterile water instead of bacteriostatic water?

Yes, sterile water for injection (WFI) or phosphate-buffered saline (PBS) can be used. However, solutions without antimicrobial preservatives should be used immediately or sub-aliquoted and frozen to prevent degradation.

What analytical methods are used to verify the purity of FLGR-242?

PX1 Research utilizes High-Performance Liquid Chromatography (HPLC) to establish purity (>98%) and Mass Spectrometry (MS) to confirm exact molecular mass. Lot-matched COAs are provided for verification.

What is the endotoxin threshold for PX1 Research compounds?

All research compounds undergo LAL endotoxin testing to ensure levels remain below established threshold limits (typically <0.1 EU/mg), making them suitable for sensitive cell cultures and in vivo preclinical models.

How long can reconstituted FLGR-242 be stored at -20°C?

When sub-aliquoted into low-binding micro-centrifuge tubes, reconstituted FLGR-242 stock solutions remain stable at -20°C to -80°C for 3 to 6 months. Repeated freeze-thaw cycles must be avoided.

How does FLGR-242 differ structurally from Follistatin-344?

FLGR-242 is an engineered peptide derivative focusing specifically on core binding domains of the follistatin structure, designed to retain high target specificity for myostatin while offering optimized chemical stability.

Are PX1 Research compounds suitable for veterinary or human administration?

No. All products supplied by PX1 Research, including FLGR-242, are strictly intended for laboratory in vitro and preclinical research applications. Human or veterinary use is strictly prohibited.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.